Inhibitor Report for: ST052207
ST052207 | Type | Quinoline |
| | Carbazol |
| Other_Name (6) |
| Chemical_Nomenclature | oxolan-2-ylmethyl 4-(9-ethylcarbazol-3-yl)-2-methyl-5-oxo-4,6,7,8-tetrahydro-1H-quinoline-3-carboxylate |
| Formula | C30H32N2O4 |
| MW | 484.58 |
| |
| Paper | Dighe_2016_J.Med.Chem_59_7683 |
| Structure | 5K5E |
| Comment | highly selective BChE inhibitor |
| Gene_locus | human-BCHE |
| CID | 2891624 |
| Family | BCHE |
| InChIKey | SHBFRAVLHSPWTB-UHFFFAOYSA-N |
| CanonicalSMILES | CCN1C2=C(C=C(C=C2)C3C4=C(CCCC4=O)NC(=C3C(=O)OCC5CCCO5)C)C6=CC=CC=C61 |
| InChI | InChI=1S/C30H32N2O4/c1-3-32-24-11-5-4-9-21(24)22-16-19(13-14-25(22)32)28-27(30(34)36-17-20-8-7-15-35-20)18(2)31-23-10-6-12-26(33)29(23)28/h4-5,9,11,13-14,16,20,28,31H,3,6-8,10,12,15,17H2,1-2H3 |
|
|